We have reported, previously, some effect of allogenic hepatic cells for islet tolerance when they are injected mixed (hepatic cells and islets) in different proportions via portal vein, in diabetic Wistar rats. Now we have studied the role of allogenic hepatic cells injected sequentially 15 min before islets, comparing via the portal vein (A and B groups) and via the cava vein (C and D groups) with a control group of islets alone. The allogenic islets were always injected via portal vein, in similar conditions, while the ratio of hepatic cells/ islets was 100:1 (A, C groups) or 200:1 (B, D groups). Islets and hepatic cells were obtained from several different rats. The transplanted rats were observed during 30 days and results compared among the different rat groups: porta-porta (P/P), cava-porta (C/P), and control group. Statistically, a significant interaction between type of transplant and proportion of hepatic cells was observed. Also, C plus D groups showed statistical difference with the control group (p < 0.017) and also all the groups together (p < 0.047). These results suggest that hepatic cells can induce, in some cases, islet graft prolongation in Wistar rats. Better results were obtained when hepatic cells were injected via the cava vein than via the portal vein. Because we used a liver cell suspension integrated for several kinds of cells, the study does not clarify if this effect can be related to some specific hepatic cell subpopulation. To confirm the results and to determine if the hypothetical mechanism can be attributed to a block of the immune system or to some factor secreted by hepatic cells, more studies must be performed.
INTRODUCTION
tumor diseases could be avoided. However, the search for new methods of engraftment without immunosuppressive drugs must continue if we are to cure diabetes Restoration of euglycemia is a target for diabetes that can be achieved by islet transplantation. The need for immuno-before complications develop. Some reports of Selawry and Cameron (19) showed suppression is a handicap that can harm the islets, hinder their function and survival, and produce some complications that Sertoli cells cotransplanted with islets were able to induce tolerance and long-term reversion of diabetes with-such as infectious diseases and tumor in the recipients.
The Edmonton group (15, 16, 20) , using new strate-out immunosuppressive drugs. It was explained by FasL expression by testicular tissue and Sertoli cells (9,21). gies, has achieved insulin independence in selected type I diabetic patients after transplantation of pancreatic
As the effect was also induced by testicular tissue transplanted separately (21), some factor(s) secreted, and not islets without kidney graft, and with an immunosuppressive regimen consisting in three drugs without glucocor-intermembrane reaction, may be the explanation of this improved islet implantation. ticoids. This work marks a new method for islet transplantation in humans, in contrast with modest results of Previous experiences of our team suggested some influence of hepatic cells on islet tolerance (8). Afterwards, the past years (3) when in most cases it was combined with kidney transplantation. Avoiding glucocorticoids, we performed new experiments without mixing hepatic cells and islets, injecting first the liver cells into the por-Shapiro's group (15, 16, 20) eludes insulin resistance and also may improve long-term prognosis if infectious and tal or cava vein, and then, after 15 min, injecting the 892 JARA-ALBARRÁ N islets always into the portal vein. In any case, we have modified from Seglen (18) , first with saline and heparin solution, then with collagenase solution (Sigma V) at not employed immunosuppressive drugs. different times, usually at 10 and 15 min. A Neubauer chamber was used for counting and trypan blue staining MATERIALS AND METHODS for viability. Next, liver cells were maintained in suspension in calcium-and magnesium-free Hank's solu-Wistar rats, not syngeneic, from different litters, weighing 200-350 g and bred in the Hospital Experi-tion until injection into the portal or cava vein in several recipient female rats. mental Building, were used for all experiments. Rats were maintained in cages with a 12-h dark/light cycle Morphodynamic analysis of hepatic cells by videointervalometry allowed to calculate the proportion of the and fed with commercial laboratory chow (Letica) and tap water ad libitum. main cell types ( Fig. 1) : hepatocytes (HC) 29%, Kupffer cells (K) 13%, epithelioid (EP) and fibroblastoid cells Diabetes was induced by streptozotocin (60 mg/kg, IP) and confirmed after three or more blood glucose lev-(F) 28%, lymphocytes (LF) 14%, granulocytes (GR) 4%, endothelioid cells (EN) 5%, other cells of difficult els of 350 mg or higher on different days, measured with Gluco Touch strips between 1200 and 1300 h. Duration filiations (O) 7%. For surgical procedure, after parenteral anesthesia of diabetes, previous to islet transplantation, was similar in all the groups studied, and ranged from 10 to 20 days. and laparotomy, hepatic cells were injected into the portal vein (A and B groups) or into the cava vein (C and A mixture of islets from several Wistar male rats was used for transplantation to diabetic females rats. Islets D groups) and, after a period of 15 min, islets were injected into the portal vein in all groups. were isolated by intraductal collagenase technique and purified by BSA gradients (1,4,10). Then they were cul-
The number of islets transplanted (ENI) was 1667.77 ± 239.02, with a purity of 90%, similar in all groups. The tured in CMRL 1066 medium, supplemented with fetal bovine serum, during 2-4 days before transplantation.
ratio of hepatic cells/islets was 100:1 (A, C groups) and 200:1 (B, D groups). In the control group (E) islets were Purity and islet number were assessed by dithizone staining (11) and expressed as "equivalent number of islets" transplanted alone, without hepatic cells. No immunosuppressive drugs were used in any group. (ENI) (14).
A liver from a male rat was obtained, each time, for In summary, the five groups studied were: (A) hepatic cells via portal vein, ratio 100:1 (N = 10 rats; ENI isolation of hepatic cells, using a double perfusion method, 
± 105); (B) hepatic cells via portal vein, ratio 200:
to analyze which were the groups that showed significant differences. 1 (N = 9 rats; ENI 1595 ± 117); (C) hepatic cells via cava vein; ratio 100:1 (N = 8 rats; ENI 1632 ± 124); (D) For histological examination hepatic and pancreatic tissues were fixed with 10% buffered formalin and em-hepatic cells via cava vein; ratio 200:1 (N = 8 rats; ENI 1845 ± 182); (E) islets alone via portal vein (N = 6; ENI bedded in paraffin. Immunohistochemical determination of insulin-producing cells in hepatic and pancreatic tis-1812 ± 457).
All rats were observed during 1 month, monitoring sues was performed using the streptavidin-biotin peroxidase complex method. Monoclonal anti-insulin (Sigma weight and glycemia. Blood glucose was measured with Gluco Touch strips at 1, 2, 3, 4, 5, 6, 7, 9, 11, 18, 25, and Immuno-Chemical, G-26654) was used as the primary antibody. 30 days after transplantation. Values of 150 mg/dl or lower were considered euglycemic, and less than 250 RESULTS mg/dl as functional islets.
Two-way ANOVA from SPSS and nonparametric Figure 2 shows the evolution of blood glucose in the five groups of rats during the follow-up period. The tests were applied for statistical study, because of the small sample size. To analyze the differences among the analysis of data with ANOVA showed a great interaction between type of transplant (P/P vs. C/P) and propor-groups, we used the Kruskal-Wallis test. When the differences were significant, Mann-Whitney U-test was used tion of hepatic cells (100:1 vs. 200:1), with a signifi- cance of p < 0.01. With Mann-Whitney U-test, group D study, although it was significantly higher in group A ( p < 0.05) at entry of the study, without changes during the showed a value of p < 0.054 compared with the control group, while no differences were found between other follow-up period. Histologic studies of liver and pancreas, from the dif-individual groups and the control group. However, there was statistical significance between the control group ferent euglycemic rats for more than 30 days, were performed. Liver pieces showed insulin-producing cell ag-(E) and all the groups together ( p < 0.047) and with groups C + D (p < 0.017). gregates (Fig. 3) , of different size, while there was a remarkable decrease of insulin-producing cells in the re-Considering individual results (Table 1) , three rats of group A, two of group D, and one of group C showed maining islets of pancreas tissue. euglycemia for more than 30 days and also one of group DISCUSSION A during 18 days, while none of group B and the control group (E) was euglycemic for a period longer than 8
Our previous experiences (8) showed some favorable influence of hepatic cells on islet implantation, without days.
The weight of the rats did not change during the immunosuppressive drugs, when they were injected mixed in the portal vein. The present work suggests that the These observations may be considered as preliminary and need further evaluations. Also, more studies are helper effect of hepatic cells is also manifested without mixing with islets, because liver cells were injected into needed to uncover the mechanisms implicated (5) and the type of implicated hepatic cells. the cava vein 15 min before islet. The fact that the results with liver cells injected into the portal vein were ACKNOWLEDGMENT: This work was supported by a grant not significant may be related to the small sample size of hepatocytes in tolerance of small bowel allografts in
